FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...